期刊
NEUROTHERAPEUTICS
卷 9, 期 2, 页码 262-269出版社
SPRINGER
DOI: 10.1007/s13311-012-0116-y
关键词
Diabetic neuropathy; Diabetic autonomic neuropathy; Chemotherapy; Toxic neuropathy; Human immunodeficiency virus; HIV-associated sensory neuropathy
资金
- National Institutes of Health [NS43991]
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- Foundation for Peripheral Neuropathy
Peripheral neuropathies are common neurological diseases, and various animal models have been developed to study disease pathogenesis and test potential therapeutic drugs. Three commonly studied disease models with huge public health impact are diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, and human immunodeficiency virus-associated sensory neuropathies. A common theme in these animal models is the comprehensive use of pathological, electrophysiological, and behavioral outcome measures that mimic the human disease. In recent years, the focus has shifted to the use of outcome measures that are also available in clinical use and can be done in a blinded and quantitative manner. One such evaluation tool is the evaluation of epidermal innervation with a simple skin biopsy. Future clinical trials will be needed to validate the translational usefulness of this outcome measure and validation against accepted outcome measures that rely on clinical symptoms or examination findings in patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据